AsiaMedic 505

SGD 0.017 -5.88% 0.00 Updated 17 Nov 2026, 17:16 SGT

Company profile

The business, the people and the ownership behind AsiaMedic.

Business overview

About the company

AsiaMedic is an integrated healthcare provider in Singapore. Its services span diagnostic imaging, health screening and primary healthcare, including medical wellness and screening services delivered through its facilities.

Annual Report 2025 ↗ Reviewed 2026-10-23 · Source dated 2026-04-13. PDF p. 5

Listed security

Company & listing

Full Company Name
ASIAMEDIC LIMITED
Trading Currency
SGD
Website
www.asiamedic.com.sg
Listing
Listed on 30 September 1987 on SGX Sesdaq
Listing Board
CATALIST
ISIN Code
SG0505000059

Board & management

Leadership

Mr Charles Wang Chong Guang

Non-Executive Chairman

Ms Aona Liu

Non-Executive Director

Ms Alice Ng Bee Yee

Independent Director

Mr Chua Keng Woon

Independent Director

Mr Leong Yew Meng

Independent Director

Mr Arifin Kwek

Chief Executive Officer (“CEO”)

Roles listed in ASIAMEDIC LIMITED ANNUAL REPORT 2025; current appointments are not independently verified.

Holdings

Ownership

Integral Lead Limited

Direct interest: 358,471,030 shares, 31.74%; deemed interest: – shares, –

As shown in the Register of Substantial Shareholders; as at 19 March 2026

Aona Liu

Direct interest: – shares, –; deemed interest: 358,471,030 shares, 31.74%

As shown in the Register of Substantial Shareholders; as at 19 March 2026

Alina W Liu

Direct interest: – shares, –; deemed interest: 358,471,030 shares, 31.74%

As shown in the Register of Substantial Shareholders; as at 19 March 2026

Dragon Glorious Limited

Direct interest: 76,813,516 shares, 6.80%; deemed interest: – shares, –

As shown in the Register of Substantial Shareholders; as at 19 March 2026

Yang Rongbing

Direct interest: – shares, –; deemed interest: 76,813,516 shares, 6.80%

As shown in the Register of Substantial Shareholders; as at 19 March 2026

Su Kajia

Direct interest: – shares, –; deemed interest: 76,813,516 shares, 6.80%

As shown in the Register of Substantial Shareholders; as at 19 March 2026

Capital Blaze Limited

Direct interest: 76,813,516 shares, 6.80%; deemed interest: – shares, –

As shown in the Register of Substantial Shareholders; as at 19 March 2026

Yuan Huixian

Direct interest: – shares, –; deemed interest: 76,813,516 shares, 6.80%

As shown in the Register of Substantial Shareholders; as at 19 March 2026

Total interests include direct and deemed holdings and may overlap across holders. These percentages should not be added together.

Registered & depository holders 20 holders

Registered holdings, including nominees and depositories; these do not establish ultimate beneficial ownership. As reported at 2026-03-19 · PDF p. 97

Registered holderInterestShares / unitsSource
INTEGRAL LEAD LIMITED358,471,030 shares; 31.74%PDF p. 972026-03-19
CAPITAL BLAZE LIMITED76,813,516 shares; 6.80%PDF p. 972026-03-19
DRAGON GLORIOUS LIMITED76,813,516 shares; 6.80%PDF p. 972026-03-19
UNITED OVERSEAS BANK NOMINEES P L63,899,598 shares; 5.66%PDF p. 972026-03-19
ANG HAO YAO (HONG HAOYAO)58,937,200 shares; 5.22%PDF p. 972026-03-19
DBS NOMINEES PTE LTD45,528,900 shares; 4.03%PDF p. 972026-03-19
PHILLIP SECURITIES PTE LTD17,401,300 shares; 1.54%PDF p. 972026-03-19
UOB KAY HIAN PTE LTD13,238,000 shares; 1.17%PDF p. 972026-03-19
MAYBANK SECURITIES PTE. LTD.12,960,800 shares; 1.15%PDF p. 972026-03-19
OCBC SECURITIES PRIVATE LTD9,269,600 shares; 0.82%PDF p. 972026-03-19
ANG KIM JOO MATTHEW8,268,400 shares; 0.73%PDF p. 972026-03-19
LEE CHYE ONN @SOW CHYE ONN8,000,000 shares; 0.71%PDF p. 972026-03-19
LISTIAWATI7,454,000 shares; 0.66%PDF p. 972026-03-19
LOO TIONG KHENG6,099,900 shares; 0.54%PDF p. 972026-03-19
OCBC NOMINEES SINGAPORE PTE LTD5,916,100 shares; 0.52%PDF p. 972026-03-19
TOK BOON CHOO5,700,000 shares; 0.50%PDF p. 972026-03-19
SSK INVESTMENTS O/S PTY LTD5,544,000 shares; 0.49%PDF p. 972026-03-19
TAN KOK HENG5,000,000 shares; 0.44%PDF p. 972026-03-19
RAFFLES NOMINEES(PTE) LIMITED4,981,700 shares; 0.44%PDF p. 972026-03-19
DBS VICKERS SECURITIES (S) PTE LTD4,520,000 shares; 0.40%PDF p. 972026-03-19

Group structure

Main operating subsidiaries

CompanyMarketOwnership interest
The Orchard Imaging Centre Pte. Ltd.Held by the Company; Group's effective equity interest 2025 (2024: 100); incorporated in Singapore 100
AsiaMedic Wellness Assessment Centre Pte. Ltd.Held by the Company; Group's effective equity interest 2025 (2024: 100); incorporated in Singapore 100
AsiaMedic PET/CT Centre Pte. Ltd.Held by the Company; Group's effective equity interest 2025 (2024: 100); incorporated in Singapore 100
Complete Healthcare International Pte. Ltd.Held by the Company; Group's effective equity interest 2025 (2024: 100); incorporated in Singapore 100
AMC Healthcare Pte. Ltd.Held by the Company; Group's effective equity interest 2025 (2024: 100); incorporated in Singapore 100
AsiaMedic Eye Centre Pte. Ltd.Held by the Company; Group's effective equity interest 2025 (2024: 100); incorporated in Singapore 100
AsiaMedic Astique The Aesthetic Clinic Pte. Ltd. [a]Held by AsiaMedic Wellness Assessment Centre Pte. Ltd.; Group's effective equity interest 2025 (2024: 100); incorporated in Singapore –
AsiaMedic Sunway Pte. Ltd.Held by AMC Healthcare Pte. Ltd.; Group's effective equity interest 2025 (2024: 50); incorporated in Singapore 50

Ownership interests and geographic information follow the annual report. Comparative years and footnote markers retain the report’s notation.

Senior executives

Key management

Key management

ItemValuePeriod / scopeSource
MR ARIFIN KWEK ZHI BIN Chief Executive Officer PDF p. 11
MS YU HUI XUAN SYENNY Chief Financial Officer PDF p. 11
DR FIONA CHANG Asst. Medical Director; Complete Healthcare International Pte Ltd PDF p. 11
DR RAPHAEL YIIN Consultant Radiologist PDF p. 12
DR LOW KAH BOON Consultant Radiologist PDF p. 12
DR DAVID SIA Consultant Radiologist PDF p. 12

Extracted from ASIAMEDIC LIMITED ANNUAL REPORT 2025 and checked against the cited pages; see the original report for full context.

Shareholding statistics

Share capital & shareholders

Share capital

ItemValuePeriod / scopeSource
Issued & Paid-Up Capital S$33,394,437 Company · As at 2026-03-19 PDF p. 97
Number & Class of Shares (Excluding Treasury Shares) 1,129,522,270 Ordinary Shares Company, excluding treasury shares · As at 2026-03-19 PDF p. 97
Voting Rights One Vote per Ordinary Share Company · As at 2026-03-19 PDF p. 97

Treasury shares

ItemValuePeriod / scopeSource
Treasury Shares & Percentage 100,000 Ordinary Shares (0.01%) Company · As at 2026-03-19 PDF p. 97
Notes (1) nil subsidiary holdings Company PDF p. 98

Shareholding distribution

ItemValuePeriod / scopeSource
GRAND TOTAL 2,372 holders Total shareholders · As at 2026-03-19 PDF p. 97
1 - 99 7 holders; 0.30%; 208 shares; 0.00% Size of Shareholdings band · As at 2026-03-19 PDF p. 97
100 - 1,000 108 holders; 4.55%; 81,603 shares; 0.01% Size of Shareholdings band · As at 2026-03-19 PDF p. 97
1,001 - 10,000 770 holders; 32.46%; 4,656,580 shares; 0.41% Size of Shareholdings band · As at 2026-03-19 PDF p. 97
10,001 - 1,000,000 1,405 holders; 59.23%; 200,454,819 shares; 17.75% Size of Shareholdings band · As at 2026-03-19 PDF p. 97
1,000,001 and above 82 holders; 3.46%; 924,329,060 shares; 81.83% Size of Shareholdings band · As at 2026-03-19 PDF p. 97

Free float

ItemValuePeriod / scopeSource
Shareholdings held by the public Percentage of shareholdings held by the public is approximately 49.40%, and therefore, Rule 723 of the Listing Manual (Section B: Rules of Catalist) of the Singapore Exchange Securities Trading Limited is complied with. Company · As at 2026-03-19 PDF p. 97

Extracted from ASIAMEDIC LIMITED ANNUAL REPORT 2025 and checked against the cited pages; see the original report for full context.

Related parties, people & properties

Other disclosures

Related party transactions

ItemValuePeriod / scopeSource
Purchase of consumables from associate 421,800 $ Group, 2025 (2024: 422,275) PDF p. 88
Key management personnel compensation total 751,595 $ Group, 2025 (2024: 741,354) PDF p. 89

Contingent liabilities

ItemValuePeriod / scopeSource
Security granted The Company provided a corporate guarantee for the term loan. Company · As at 2025-12-31 PDF p. 87
Deficiencies in shareholders’ funds 16,929,997 $ Company, 2025 (2024: 18,506,941) · As at 2025-12-31 PDF p. 90
Current liabilities in excess of current assets 17,118,895 $ Company, 2025 (2024: 22,052,817) · As at 2025-12-31 PDF p. 90

Director remuneration

ItemValuePeriod / scopeSource
Directors and CEO remuneration total $173,000 FY2025 total directors' fees PDF p. 31
Charles Wang $42,000 FY2025 PDF p. 31
Aona Liu $27,000 FY2025 PDF p. 31
Alice Ng $37,000 FY2025 PDF p. 31
Chua Keng Woon $35,000 FY2025 PDF p. 31
Leong Yew Meng $32,000 FY2025 PDF p. 31

Employees

ItemValuePeriod / scopeSource
Salaries and bonuses to employees 12,481,456 $ Group, 2025 (2024: 11,265,752) PDF p. 83

Outlook

ItemValuePeriod / scopeSource
OUTLOOK Looking ahead, the Group will continue to focus on strengthening its core capabilities in diagnostic imaging and preventive healthcare. Chairman's Statement PDF p. 14

Extracted from ASIAMEDIC LIMITED ANNUAL REPORT 2025 and checked against the cited pages; see the original report for full context.

Source: ASIAMEDIC LIMITED ANNUAL REPORT 2025 ↗

Corporate information

Registration & contacts

Incorporated In
SINGAPORE
Incorporated On
29 Aug 1974
Email
[email protected]
Telephone
65 67898888
Fax
65 67384136
Registered Office
350 Orchard Road #08-00
Shaw House
Singapore 238868
Secretary
Foo Soon Soo
Registrar / Transfer Agent
KCK CORPSERVE PTE. LTD.
Registrar Address
1 Raffles Place, One Raffles Place (Tower 2) #04-63, Singapore 048616
Auditors
BAKER TILLY TFW LLP
Other Stock Exchange Listings
*SINGAPORE EXCHANGE (CATALIST)
Country
SINGAPORE
Security Type
stocks